[1]
Alenezi, F. et al. 2021. Benefit/risk Ratio of Low-dose Methotrexate in Cutaneous Lesions of Mycosis Fungoides and Sézary Syndrome. Acta Dermato-Venereologica. 101, 2 (Feb. 2021), adv00384. DOI:https://doi.org/10.2340/00015555-3719.